Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease

Haematologica. 2023 Feb 1;108(2):633-637. doi: 10.3324/haematol.2022.281716.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / therapeutic use
  • Chronic Pain* / drug therapy
  • Chronic Pain* / etiology
  • Humans
  • beta-Lactams / therapeutic use

Substances

  • Ceftriaxone
  • beta-Lactams
  • Anti-Bacterial Agents